Avalere | The intersection of business strategy and public policy
Home About Avalere Health Research Portfolio News Services Events Staff Contact Us

Forum on Diabetes / Broaden Your View.  March 12-13, 2008 | Washington, DC

Avalere Health is proud to have assembled a diverse group of leaders and decision-makers in government, industry, and advocacy. These key players will engage you and each other in a dialogue on the current and future state of diabetes care in the United States. Broaden your view with the insights of these speakers at the Avalere Health Forum on Diabetes.

Speaker Profiles /

Ann Albright | John E. Anderson | Bob Atlas | Jan Berger | Jonathan Blum |
Jennifer Bowman | Perry Bridger | Carolyn M. Clancy | Keith J. Fontenot |
Judith E. Fradkin | Jon Glaudemans | Marsha Gold | Amparo Gonzalez |
Jennifer Hersh | Shannah Koss | Dan Mendelson | Joe Quinn | Jim Schlicht |
Joshua Seidman | Jaan Sidorov | Linda Siminerio | Lawrence A. Soler

 

Dan Mendelson is President and founder of Avalere Health. Avalere Health provides strategic consulting, analytic due diligence, and policy guidance for clients in industry, government, and the not-for-profit sector. Based in Washington D.C., the firm focuses on the intersection between public policy and business strategy. Avalere Health also completes objective, analytic policy research funded by major medical foundations. The firm employs a wealth of talented consultants with backgrounds in government and industry. Dan is also currently Adjunct Professor of Business Administration at The Fuqua School of Business at Duke University.

From 1998 to 2000, Dan served as Associate Director for Health at the Office of Management and Budget, the White House office responsible for creating the President’s budget and for policy coordination across the Administration. He supervised a staff of 75, and was responsible for the full healthcare portfolio including Medicare, Medicaid, NIH, CDC, and FDA. His work included development of the Administration’s pharmaceutical benefit, Presidential initiatives in health information technology and medical error prevention, the electronic disease surveillance system, and federal policies in reimbursement and technology assessment.

Prior to joining OMB, Dan was Senior Vice President of The Lewin Group and Director of the Medical Technology Practice. During his eight-year tenure he had a range of responsibilities, including management of a transnational pharmaceutical and medical device consulting practice. Between 1994 and 1996 Dan was also closely involved in the operations of Value Rx, a pharmacy benefit management company (PBM). He also actively assisted both Value Health and Quintiles Transnational in due diligence on acquisitions.

Dan has published widely in peer-reviewed and professional journals on health information technology, the costs of disease, hospital costs and operations, physician payment, the economics of managed care, medical malpractice, and a range of other topics in healthcare policy and business. He holds an undergraduate degree in economics and viola performance from Oberlin College, and a M.P.P. from the Kennedy School of Government at Harvard University.

 

 

Introduction
Agenda
Registration
 Speaker Profiles
Research
Sponsors and Partners